COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
STRATACACHE Partners With Lumiode to Bring Next Gen Active Matrix Technology to STRATACACHE's US-Based microLED Display Manufacturing
STRATACACHE announces partnership with Lumiode for manufacturing microLED display technology in the U.S. The partnership allows for in-house supply and production chain, reducing costs and bringing large format display manufacturing to the country -
COMMUNIQUÉ DE PRESSE
Preservica and GSK Set New Standard for Digital Preservation in Life Sciences
Pharmaceutical company GSK selects Preservica Enterprise for its corporate archive to ensure digital asset resilience and accessibility. The partnership represents an advancement in digital preservation standards and aims to protect critical long-term assets -
COMMUNIQUÉ DE PRESSE
Introducing Fortifeye Fit Pro
Fortifeye Fit Pro, the latest innovation from Fortifeye Vitamins, is set to revolutionize the world of sports nutrition. It's a premium-quality supplement formulated to optimize performance, enhance recovery, and support overall health. Incorporating grass-fed collagen, grass-fed whey protein, Creapure creatine, myHMB, vitamin D, PEAK ATP, L-citrulline, and betaine anhydrous, it offers a holistic solution for athletes and fitness enthusiasts -
-
COMMUNIQUÉ DE PRESSE
Boujee Beauty Launches At-Home Beauty Line Featuring NASA-Inspired Infrared Technology
Boujee Beauty introduces a new line of at-home beauty care products featuring NASA-inspired infrared technology for skin, hair, and body. Founder Shelley Goodstein discusses the benefits and mission of the wellness brand -
COMMUNIQUÉ DE PRESSE
Sigyn Therapeutics Announces Reverse Stock Split
Sigyn Therapeutics, Inc. announced a 1-for-40 reverse stock split of its common stock, aiming to gain compliance with Nasdaq listing requirements. The split will affect stockholders uniformly and is intended to increase the market price per share -
COMMUNIQUÉ DE PRESSE
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions
Magdalena Biosciences, Inc. plans to submit an Investigational New Drug application to the FDA in 2024 for a next-generation psychoactive prescription drug candidate targeting mental health indications such as ADHD, depression, and anxiety. The preclinical study in mice suggests psychoactive activity in a plant extract for potential use as a next-generation psychoactive prescription drug. Magdalena focuses on identifying safe and effective plant-based psychoactive drugs to treat mental health disorders -
COMMUNIQUÉ DE PRESSE
KYN Capital Group Announces Koinfold 2.0 is Now Available on the iOS Store
KYN Capital Group (OTC:KYNC) announces the release of Koinfold 2.0 on the iOS store. The new version offers cryptocurrency swap features, 'Learn to Earn' with play cryptocurrency, 24/7 cryptocurrency news, and more. CEO Rick Wilson emphasizes the significance of the release
